Nasdaq Inc vs Smith & Nephew plc — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Nasdaq Inc is far larger — about 4.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| NDAQ | SNN | |
|---|---|---|
Market Cap | $51.96B | $12.64B |
Sector | Financials | Health |
52-Week High | $100.98 | $38.70 |
52-Week Low | $76.85 | $28.73 |
Enterprise Value | $59.02B | $15.41B |
Dividend Yield | 1.22% | 2.57% |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →